358 related articles for article (PubMed ID: 26678258)
1. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014.
Palamar JJ; Su MK; Hoffman RS
Am J Drug Alcohol Abuse; 2016; 42(1):39-47. PubMed ID: 26678258
[TBL] [Abstract][Full Text] [Related]
2. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.
Cairns R; Brown JA; Gunja N; Buckley NA
Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112
[TBL] [Abstract][Full Text] [Related]
3. Evolution of clinical characteristics and outcomes of synthetic cannabinoid receptor agonist exposure in the United States: analysis of National Poison Data System data from 2010 to 2015.
Cordeiro SK; Daro RC; Seung H; Klein-Schwartz W; Kim HK
Addiction; 2018 Oct; 113(10):1850-1861. PubMed ID: 29806885
[TBL] [Abstract][Full Text] [Related]
4. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM
Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522
[TBL] [Abstract][Full Text] [Related]
5. Detection of "bath salts" and other novel psychoactive substances in hair samples of ecstasy/MDMA/"Molly" users.
Palamar JJ; Salomone A; Vincenti M; Cleland CM
Drug Alcohol Depend; 2016 Apr; 161():200-5. PubMed ID: 26883685
[TBL] [Abstract][Full Text] [Related]
6. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service.
Waugh J; Najafi J; Hawkins L; Hill SL; Eddleston M; Vale JA; Thompson JP; Thomas SH
Clin Toxicol (Phila); 2016 Jul; 54(6):512-8. PubMed ID: 27091041
[TBL] [Abstract][Full Text] [Related]
8. Increasing frequency and fatality of poison control center reported exposures involving medication and multiple substances: data from reports of the American Association of Poison Control Centers 1984-2013.
Greenwald PW; Farmer BM; O'Neill M; Essner RA; Flomenbaum NE
Clin Toxicol (Phila); 2016 Aug; 54(7):590-6. PubMed ID: 27214065
[TBL] [Abstract][Full Text] [Related]
9. Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene.
Palamar JJ; Salomone A; Gerace E; Di Corcia D; Vincenti M; Cleland CM
Int J Drug Policy; 2017 Oct; 48():91-98. PubMed ID: 28810159
[TBL] [Abstract][Full Text] [Related]
10. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.
Banister SD; Connor M
Handb Exp Pharmacol; 2018; 252():165-190. PubMed ID: 29980914
[TBL] [Abstract][Full Text] [Related]
11. Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances.
Fernández-Calderón F; Cleland CM; Palamar JJ
Addict Behav; 2018 Mar; 78():85-93. PubMed ID: 29128711
[TBL] [Abstract][Full Text] [Related]
12. Self-Reported Ecstasy/MDMA/"Molly" Use in a Sample of Nightclub and Dance Festival Attendees in New York City.
Palamar JJ; Acosta P; Ompad DC; Cleland CM
Subst Use Misuse; 2017 Jan; 52(1):82-91. PubMed ID: 27661470
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.
Chung EY; Cha HJ; Min HK; Yun J
Arch Pharm Res; 2021 Apr; 44(4):402-413. PubMed ID: 33811300
[TBL] [Abstract][Full Text] [Related]
14. 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database.
Lai MW; Klein-Schwartz W; Rodgers GC; Abrams JY; Haber DA; Bronstein AC; Wruk KM
Clin Toxicol (Phila); 2006; 44(6-7):803-932. PubMed ID: 17015284
[TBL] [Abstract][Full Text] [Related]
15. Suspected synthetic cannabinoid receptor agonist intoxication: Does analysis of samples reflect the presence of suspected agents?
Tebo C; Mazer-Amirshahi M; DeGeorge L; Gelfand B; Leak C; Tolliver S; Sauter D
Am J Emerg Med; 2019 Oct; 37(10):1846-1849. PubMed ID: 30595429
[TBL] [Abstract][Full Text] [Related]
16. New psychoactive substance use among regular psychostimulant users in Australia, 2010-2015.
Sutherland R; Peacock A; Whittaker E; Roxburgh A; Lenton S; Matthews A; Butler K; Nelson M; Burns L; Bruno R
Drug Alcohol Depend; 2016 Apr; 161():110-8. PubMed ID: 26880592
[TBL] [Abstract][Full Text] [Related]
17. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
[TBL] [Abstract][Full Text] [Related]
18. Adolescent synthetic cathinone exposures reported to Texas poison centers.
Forrester MB
Pediatr Emerg Care; 2013 Feb; 29(2):151-5. PubMed ID: 23364377
[TBL] [Abstract][Full Text] [Related]
19. Trends in gamma-hydroxybutyrate (GHB) and related drug intoxication: 1999 to 2003.
Anderson IB; Kim SY; Dyer JE; Burkhardt CB; Iknoian JC; Walsh MJ; Blanc PD
Ann Emerg Med; 2006 Feb; 47(2):177-83. PubMed ID: 16431231
[TBL] [Abstract][Full Text] [Related]
20. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.
Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC
Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
